Financings in Brief: Aastrom Biosciences
This article was originally published in The Gray Sheet
Executive Summary
Aastrom Biosciences: Raises $10 mil. through two $5 mil. private equity placements. Cobe BCT, Inc., a unit of Swedish firm Gambro Group, invested $5 mil. in accordance with an exclusive marketing agreement reached in 1993 ("The Gray Sheet" Nov. 15, 1993, p. 3). The remaining $5 mil. was put forth by a group including: Brentwood Associates, the Enterprise Development Fund of Ann Arbor, Hambrecht & Quist London Ventures and Life Science Technology Fund, the Northwest Ohio Venture Fund, the State of Michigan, and Wind Point Partners.